IE 11 is not supported. For an optimal experience visit our site on another browser.

FDA panel set to issue recommendation on Johnson & Johnson vaccine


On Friday the FDA’s advisory panel formally votes on whether to approve Johnson & Johnson’s single-dose vaccine for emergency use, potentially giving the U.S. a third coronavirus vaccine option. NBC’s Tom Costello reports for TODAY from a Baltimore facility where that vaccine is being manufactured.